TY - JOUR
T1 - Isoflavones and phytosterols contained in Xuezhikang capsules modulate cholesterol homeostasis in high-fat diet mice
AU - Feng, Dong
AU - Sun, Jian Guo
AU - Sun, Run Bin
AU - Ou-Yang, Bing Chen
AU - Yao, Lan
AU - Aa, Ji Ye
AU - Zhou, Fang
AU - Zhang, Jing Wei
AU - Zhang, Jian
AU - Wang, Guang Ji
N1 - Publisher Copyright:
© 2015 CPS and SIMM All rights reserved.
PY - 2015/12/3
Y1 - 2015/12/3
N2 - Aim: Xuezhikang (XZK), an extract of red yeast rice, has been widely used in traditional Chinese medicine to treat cardiovascular disease. Three fractions F1, F2 and F3 (primarily containing isoflavones, monacolins or phytosterols, respectively) are extracted from Xuezhikang capsules. In this study we evaluated the lipid-lowering effects of these fractions and explored the potential mechanisms of actions. Methods: Mice treated with a high-fat diet (HFD) were orally adminis¬tered lovastatin (10 mg·kg-1 ·d-1), XZK (1200 mg·kg-1 ·d-1), F1 (27.5 mg·kg-1 ·d-1), F2 (11.3 mg·kg-1 ·d-1) or F3 (35 mg·kg-1 ·d-1) for 10 weeks. Lipids were measured using commercial enzymatic kits, and the mRNA and protein levels of genes involved in cholesterol and bile acid homeostasis were evaluated using qRT-PCR and Western blot analysis, respectively. Results: XZK increased the fecal excretion of lipids and bile acids, reduced serum TC, TG and LDL-C levels by 40%, 55% and 46%, respectively, and increased serum HDL-C by 31%. Administration of F1 repressed serum TC and TG by 24% and 52%, respectively, and elevated hepatic synthesis of CYP7A1. It also increased hepatic elimination of bile acids in the fecal excretions by 79% through upregulating BSEP and downregulating NTCP. Administration of F3 decreased serum TC, TG and LDL-C levels by 33%, 29% and 39%, respectively, and increased serum HDL-C by 28%, sig¬nificantly reduced intestinal absorption of cholesterol by inhibiting the transcription of NPC1L1, and elevated excretion of TC, FC and CE by 96%, 72% and 101%, respectively. Administration of F2 showed pharmacological effects similar to those of lovastatin. Conclusion: Isoflavones and phytosterols in XZK exert cholesterol-lowering effects in HFD mice through mechanisms that differ from those of lovastatin. Isoflavones and phytosterols act in a complimentary manner: through enhancing the elimination of bile acids and reducing intestinal cholesterol absorption, respectively.
AB - Aim: Xuezhikang (XZK), an extract of red yeast rice, has been widely used in traditional Chinese medicine to treat cardiovascular disease. Three fractions F1, F2 and F3 (primarily containing isoflavones, monacolins or phytosterols, respectively) are extracted from Xuezhikang capsules. In this study we evaluated the lipid-lowering effects of these fractions and explored the potential mechanisms of actions. Methods: Mice treated with a high-fat diet (HFD) were orally adminis¬tered lovastatin (10 mg·kg-1 ·d-1), XZK (1200 mg·kg-1 ·d-1), F1 (27.5 mg·kg-1 ·d-1), F2 (11.3 mg·kg-1 ·d-1) or F3 (35 mg·kg-1 ·d-1) for 10 weeks. Lipids were measured using commercial enzymatic kits, and the mRNA and protein levels of genes involved in cholesterol and bile acid homeostasis were evaluated using qRT-PCR and Western blot analysis, respectively. Results: XZK increased the fecal excretion of lipids and bile acids, reduced serum TC, TG and LDL-C levels by 40%, 55% and 46%, respectively, and increased serum HDL-C by 31%. Administration of F1 repressed serum TC and TG by 24% and 52%, respectively, and elevated hepatic synthesis of CYP7A1. It also increased hepatic elimination of bile acids in the fecal excretions by 79% through upregulating BSEP and downregulating NTCP. Administration of F3 decreased serum TC, TG and LDL-C levels by 33%, 29% and 39%, respectively, and increased serum HDL-C by 28%, sig¬nificantly reduced intestinal absorption of cholesterol by inhibiting the transcription of NPC1L1, and elevated excretion of TC, FC and CE by 96%, 72% and 101%, respectively. Administration of F2 showed pharmacological effects similar to those of lovastatin. Conclusion: Isoflavones and phytosterols in XZK exert cholesterol-lowering effects in HFD mice through mechanisms that differ from those of lovastatin. Isoflavones and phytosterols act in a complimentary manner: through enhancing the elimination of bile acids and reducing intestinal cholesterol absorption, respectively.
KW - Xuezhikang
KW - bile acids
KW - cholesterol
KW - cholesterol-lowering medication
KW - hyperlipidemia
KW - isoflavones
KW - lovastatin
KW - phytosterols
KW - red yeast rice
KW - traditional Chinese medicine
UR - https://www.scopus.com/pages/publications/84949213750
U2 - 10.1038/aps.2015.98
DO - 10.1038/aps.2015.98
M3 - 文章
C2 - 26592515
AN - SCOPUS:84949213750
SN - 1671-4083
VL - 36
SP - 1462
EP - 1472
JO - Acta Pharmacologica Sinica
JF - Acta Pharmacologica Sinica
IS - 12
ER -